Michael Folkert, MD, PhD
Professor
Radiation Oncology Division, Fred Hutch
Dr. Michael R. Folkert is a radiation oncologist who specializes in prostate cancer and cancers of the soft tissue and bone (sarcomas). He is also chief of brachytherapy and the physician lead of the Radio-Isotope Program at the University of Washington School of Medicine. He has nearly 20 years of clinical experience in radiation oncology using advanced brachytherapy techniques and devices for the treatment of brain, ocular, spine, thoracic, gastrointestinal, genitourinary, gynecologic and musculoskeletal malignancies. He is an expert in optimal multidisciplinary management of primary malignancies of the prostate, bones and soft tissues and in applications of radiopharmaceutical therapy.
After graduating from the Harvard/MIT Health Sciences and Technology joint program with a doctorate in radiological sciences and a medical degree, Dr. Folkert completed a residency in radiation oncology at Memorial Sloan Kettering Cancer Center and a fellowship in clinical research methodology at Weill Cornell Medical College Clinical and Translational Science Center. It is his goal to combine engineering and medical physics with clinical expertise in radiation oncology to develop approaches to curing or managing cancer with the lowest possible morbidity.
Dr. Folkert is a representative on the U.S. Nuclear Regulatory Commission Advisory Committee on Medical Uses of Isotopes. He has contributed to over 100 published works and over 2000 citations. Dr. Folkert is board-certified in radiation oncology by the American Board of Radiology.
Other Appointments & Affiliations
Physician, Fred HutchPhysician
Fred Hutch
Professor; Chief of Brachytherapy Program; Physician Lead of Radio-Isotope Program
Department of Radiation Oncology, University of Washington School of Medicine
Brachytherapy Representative
U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on Medical Uses of Isotopes (ACMUI)
Education
Residency, Radiation Oncology, Memorial Sloan Kettering Cancer Center, 2014
Fellowship, Clinical Research Methodology Program, Weill Cornell Medical College Clinical and Translational Science Center, NIH UL1TR000457 K30 Award, 2013
MD Medicine, Harvard-MIT Division of Health Sciences and Technology, 2009
PhD Radiological Sciences, Harvard-MIT Division of Health Sciences and Technology, 2005
BS/MS Nuclear Engineering, Massachusetts Institute of Technology, 1998
Diseases Researched
Prostate cancer
Sarcoma
Research Focus
Brachytherapy applications
Intraoperative radiation therapy
Theranostics/radiopharmaceutical therapies
Toxicity mitigation strategies
Clinical outcomes
Current Projects
Salvage brachytherapy for radiorecurrent disease
Organ displacement and hypothermia for radiation toxicity reduction
Optimization of radioisotope production and automation of radioligand production
Adaptive and hypofractionated approaches in sarcoma
Neutron therapy for radiation insensitive/radiorecurrent malignancies
Metastasis directed therapy
Clinical Expertise
Prostate cancer
Sarcoma (soft tissue and bone)
Board Certification
Radiation Oncology, 2015, American Board of Radiology
"I strive to combine my background in engineering and medical physics with my clinical expertise in radiation oncology to develop approaches to cure or manage cancer with the lowest possible morbidity."
— Dr. Michael R. Folkert